0.0068USD-1.45%Mkt Cap: —P/E: —3d ago
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead produc…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-20.43M $
Revenue/Share—
Last Price0.0068 USD
Fiscal Year End—
MR Quarter—
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)—
EPS (Forward)—
52W Range
0.002651% of range0.0109
52W High0.0109 USD
52W Low0.0026 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-36.99%
ROA-33.91%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.21M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-45.66M $
Net Debt/EBITDA2.39
Balance Sheet
Debt/Equity—
Current Ratio26.25
Quick Ratio24.84
Book Value/Sh1.492 USD
Cash/Share1.367 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float21.09M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)3.44K
Avg Vol (10d)—
Technical Indicators
RSI (14)43.6
MACD-0.0011
MACD Signal-0.0007
MACD Hist.-0.0004
BB Upper0.0141 USD
BB Middle0.0095 USD
BB Lower0.0048 USD
BB Width98.03%
ATR (14)0.0018 USD
Vol Ratio (20d)13.69x